Operating performance also strengthened significantly, with consolidated EBITDA climbing 55% year-on-year to Rs 36.52 crore
The biopharma division of IGL reported net revenue of Rs 246 crore, EBITDA of Rs 29 crore and a gross margin of 40.1% in FY26
International operations emerged as the biggest growth driver, posting a 34.5% increase in revenue to Rs 16,652 million
Under the deal, Fresenius will retain exclusive global commercialization rights, including marketing authorizations
Clinical results suggest significant potential
India FMCG business grows 10.7%; International business grows 20%
The expanded collaboration combines DifGen’s development and US manufacturing capabilities with Alembic’s established US commercial platform
Wegovy pill generates DKK 5.4 billion in quarterly sales as GLP-1 demand fuels growth
Strong growth across US, Europe and emerging markets drives 24% revenue surge
The company reported sales of Rs 7,785.5 crore for Q2 FY27
The move will give Merck a more concentrated Life Science portfolio
While Pharmaceuticals gathered momentum, Crop Science and Consumer Health continued to perform in line with their respective targets despite challenging market conditions
A major growth driver was Pfizer's launched and acquired product portfolio, which recorded a striking 32% year-over-year operational revenue increase.
The project will add 160,000 litres of manufacturing capacity, increasing the facility's total capacity by approximately 25% to nearly one million litres
Akums has expanded beyond pharmaceutical manufacturing by acquiring Oriflame India's manufacturing business for Rs 56 crore
The diagnostics major has also roped in actor Yami Gautam Dhar as the brand ambassador for the new product
Deal marks a strategic shift for Enzene towards a focused global CDMO business
Subscribe To Our Newsletter & Stay Updated
